CN103845553A - Traditional Chinese medicine for treating myocarditis - Google Patents
Traditional Chinese medicine for treating myocarditis Download PDFInfo
- Publication number
- CN103845553A CN103845553A CN201310745650.4A CN201310745650A CN103845553A CN 103845553 A CN103845553 A CN 103845553A CN 201310745650 A CN201310745650 A CN 201310745650A CN 103845553 A CN103845553 A CN 103845553A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- traditional chinese
- myocarditis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses traditional Chinese medicine for treating myocarditis. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 20-35 parts of salvia miltiorrhiza, 10-20 parts of safflower, 7-16 parts of dried radix rehmanniae, 14-22 parts of schisandra chinensis, 10-22 parts of pinellia, 9-16 parts of dried orange peel, 10-20 parts of cassia twig, 5-12 parts of arisaema cum bile, 7-14 parts of puerarin, 8-14 parts of elecampane and 5-10 parts of peucedanum. According to the traditional Chinese medicine for treating myocarditis disclosed by the invention, salvia miltiorrhiza is used as the main drug and matched with other auxiliary drugs, the main drug and the auxiliary drugs mutually influence and cooperate, thus playing good functions of supplementing qi, nourishing yin, soothing the nerves and calming and promoting blood circulation to remove blood stasis, and the traditional Chinese medicine has a good curative effect on myocarditis patients and is safe, free of side effect, simple in preparation method and convenient to take.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat myocarditic Chinese medicine.
Background technology
Myocarditis refers to the myocardium Lymph nodes that a variety of causes causes.Many factors as infected, physics and chemistry factor all can cause myocarditis, the light and heavy degree difference of the cardiac damage causing is very large, clinical manifestation is different, patient with slight symptoms is without any symptom, and patient with severe symptoms can heart failure occur, cardiogenic shock is even died suddenly.Most of patient can obtain recovery from illness through treatment, and some patient develops into dilated cardiomyopathy and changes after acute stage, and heart failure can occur repeatedly.The myocarditic medicine for the treatment of is a lot of at present, and for example publication number is: CN101095885, name are called the Chinese invention patent application of " one is treated myocarditic Chinese medicine ", and it relates to a kind of Chinese medicine for the treatment of heart disease.The myocarditic Chinese medicine of this treatment is made up of the Radix Astragali, Radix Codonopsis, Radix Ophiopogonis, Radix Rehmanniae Preparata, Poria cum Radix Pini, Herba Taraxaci, Gypsum Fibrosum, the Rhizoma Pinelliae, Bulbus Fritillariae Thunbergii, Radix Scutellariae, Herba Lophatheri, Radix Angelicae Sinensis, Radix Polygalae, Arisaema Cum Bile, Fructus Amomi Rotundus, Rhizoma Acori Graminei, Radix Glycyrrhizae.The present invention treats that myocarditic Chinese herbal medicine specimen is double to be controlled, and has QI invigorating and enriches blood, nourishing YIN and clearing away heat, the effect of tranquilizing by nourishing the heart, eliminating pathogenic factor for supporting vital QI.Can be used for not normal, uncomfortable in chest weak, the spontaneous perspiration of shortness of breath and palpitation, heart arteries and veins that treatment causes because of myocarditis, lassitude of the limbs and mind, precordialgia and severe palpitation, irregularly intermittent and regularly intermittent pulse.Patient takes 4~12 weeks rear therapeutic effect ideals of medicine of the present invention, and myocarditis symptom is obviously improved or disappeared, and total effective rate is 99%, and cure rate is higher than 95%, and relapse rate is low.But the compatibility more complicated of this medicine.
Summary of the invention
The technical problem to be solved in the present invention is to provide the myocarditic Chinese medicine for the treatment of that a kind of compatibility is comparatively simple, safe and reliable, therapeutic effect is good.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats myocarditic Chinese medicine, is to be made up of the raw material of following weight proportioning:
Radix Salviae Miltiorrhizae 20~35, Flos Carthami 10~20, the Radix Rehmanniae 7~16, Fructus Schisandrae Chinensis 14~22, the Rhizoma Pinelliae 10~22, Pericarpium Citri Reticulatae 9~16, Ramulus Cinnamomi 10~20, Arisaema Cum Bile 5~12, Radix Puerariae 7~14, the Radix Aucklandiae 8~14, Radix Peucedani 5~10.
The preferred weight proportioning of each raw material is:
Radix Salviae Miltiorrhizae 24~30, Flos Carthami 12~18, the Radix Rehmanniae 9~14, Fructus Schisandrae Chinensis 16~20, the Rhizoma Pinelliae 13~20, Pericarpium Citri Reticulatae 11~15, Ramulus Cinnamomi 12~18, Arisaema Cum Bile 6~9, Radix Puerariae 9~12, the Radix Aucklandiae 9~12, Radix Peucedani 6~9.
The optimum weight proportioning of each raw material is:
Radix Salviae Miltiorrhizae 26, Flos Carthami 16, the Radix Rehmanniae 12, Fructus Schisandrae Chinensis 18, the Rhizoma Pinelliae 17, Pericarpium Citri Reticulatae 13, Ramulus Cinnamomi 16, Arisaema Cum Bile 8, Radix Puerariae 10, the Radix Aucklandiae 10, Radix Peucedani 7.
The preparation method that the present invention treats myocarditic Chinese medicine is: take by weight ratio raw material Radix Salviae Miltiorrhizae, Flos Carthami, the Radix Rehmanniae, Fructus Schisandrae Chinensis, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Ramulus Cinnamomi, Arisaema Cum Bile, Radix Puerariae, the Radix Aucklandiae, Radix Peucedani, add the decocting of 8~12 times of raw material weights to boil, after water boils, slow fire boils 50~80 minutes, leach medicinal liquid, to obtain final product.
The instructions of taking that the present invention treats myocarditic Chinese medicine is: oral, every day 2 times, each serving 300~400 grams.
The present invention treats myocarditic Chinese medicine taking Radix Salviae Miltiorrhizae as principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good supplementing QI and nourishing YIN, calm the nerves surely throb with fear, blood circulation invigorating efficacies, patients with myocarditis is had to good therapeutic effect, and it has no side effect safely, preparation method is simple, and it is also convenient to take.
Detailed description of the invention
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
20 parts of Radix Salviae Miltiorrhizaes, 10 parts, Flos Carthami, 7 parts, the Radix Rehmanniae, 14 parts of Fructus Schisandrae Chinensis, 10 parts of the Rhizoma Pinelliaes, 9 parts of Pericarpium Citri Reticulataes, 10 parts of Ramulus Cinnamomi, 5 parts of Arisaema Cum Bile, 7 parts of Radix Puerariaes, 8 parts of the Radix Aucklandiae, 5 parts of Radix Peucedanis.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 50 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 2
Drug weight proportioning:
35 parts of Radix Salviae Miltiorrhizaes, 20 parts, Flos Carthami, 16 parts, the Radix Rehmanniae, 22 parts of Fructus Schisandrae Chinensis, 22 parts of the Rhizoma Pinelliaes, 16 parts of Pericarpium Citri Reticulataes, 20 parts of Ramulus Cinnamomi, 12 parts of Arisaema Cum Bile, 14 parts of Radix Puerariaes, 14 parts of the Radix Aucklandiae, 10 parts of Radix Peucedanis.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 65 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 3
Drug weight proportioning:
26 parts of Radix Salviae Miltiorrhizaes, 16 parts, Flos Carthami, 12 parts, the Radix Rehmanniae, 18 parts of Fructus Schisandrae Chinensis, 17 parts of the Rhizoma Pinelliaes, 13 parts of Pericarpium Citri Reticulataes, 16 parts of Ramulus Cinnamomi, 8 parts of Arisaema Cum Bile, 10 parts of Radix Puerariaes, 10 parts of the Radix Aucklandiae, 7 parts of Radix Peucedanis.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 12 times of raw material weights to boil, after water boils, slow fire boils 80 minutes, leaches medicinal liquid, to obtain final product.
Experimental example:
Below example is further set forth the present invention and treats the beneficial effect of myocarditic Chinese medicine by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: myocarditis female patient 67 examples; 20~45 years old age.
B group: myocarditis male patient's 79 examples; 20~40 years old age.
2, drug administration method:
The oral embodiment of the present invention 3 makes the myocarditic Chinese medicine for the treatment of every day 2 times, each serving 400 grams, serve on 45 days.
3, efficacy evaluation:
(1) invalid: compared with before taking medicine, without significant change.
(2) effective: effect is remarkable.
4, therapeutic effect:
Claims (3)
1. the myocarditic Chinese medicine for the treatment of, it is characterized in that being made up of the raw material of following weight proportioning:
Radix Salviae Miltiorrhizae 20~35, Flos Carthami 10~20, the Radix Rehmanniae 7~16, Fructus Schisandrae Chinensis 14~22, the Rhizoma Pinelliae 10~22, Pericarpium Citri Reticulatae 9~16, Ramulus Cinnamomi 10~20, Arisaema Cum Bile 5~12, Radix Puerariae 7~14, the Radix Aucklandiae 8~14, Radix Peucedani 5~10.
2. the myocarditic Chinese medicine for the treatment of according to claim 1, is characterized in that the weight proportion of each raw material is:
Radix Salviae Miltiorrhizae 24~30, Flos Carthami 12~18, the Radix Rehmanniae 9~14, Fructus Schisandrae Chinensis 16~20, the Rhizoma Pinelliae 13~20, Pericarpium Citri Reticulatae 11~15, Ramulus Cinnamomi 12~18, Arisaema Cum Bile 6~9, Radix Puerariae 9~12, the Radix Aucklandiae 9~12, Radix Peucedani 6~9.
3. the myocarditic Chinese medicine for the treatment of according to claim 2, is characterized in that the weight proportion of each raw material is:
Radix Salviae Miltiorrhizae 26, Flos Carthami 16, the Radix Rehmanniae 12, Fructus Schisandrae Chinensis 18, the Rhizoma Pinelliae 17, Pericarpium Citri Reticulatae 13, Ramulus Cinnamomi 16, Arisaema Cum Bile 8, Radix Puerariae 10, the Radix Aucklandiae 10, Radix Peucedani 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310745650.4A CN103845553A (en) | 2013-12-30 | 2013-12-30 | Traditional Chinese medicine for treating myocarditis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310745650.4A CN103845553A (en) | 2013-12-30 | 2013-12-30 | Traditional Chinese medicine for treating myocarditis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103845553A true CN103845553A (en) | 2014-06-11 |
Family
ID=50853957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310745650.4A Pending CN103845553A (en) | 2013-12-30 | 2013-12-30 | Traditional Chinese medicine for treating myocarditis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103845553A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105582308A (en) * | 2015-10-15 | 2016-05-18 | 张金祝 | Traditional Chinese medicine composition for treating myocarditis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1903322A (en) * | 2006-08-15 | 2007-01-31 | 倪文城 | Medicine for treating myocarditis |
CN103007225A (en) * | 2012-12-03 | 2013-04-03 | 王年 | Pure traditional Chinese medicine composition for curing vital myocarditis |
CN103230457A (en) * | 2013-05-09 | 2013-08-07 | 徐金星 | Traditional Chinese medicine composition for treating viral myocarditis and preparation method and use thereof |
-
2013
- 2013-12-30 CN CN201310745650.4A patent/CN103845553A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1903322A (en) * | 2006-08-15 | 2007-01-31 | 倪文城 | Medicine for treating myocarditis |
CN103007225A (en) * | 2012-12-03 | 2013-04-03 | 王年 | Pure traditional Chinese medicine composition for curing vital myocarditis |
CN103230457A (en) * | 2013-05-09 | 2013-08-07 | 徐金星 | Traditional Chinese medicine composition for treating viral myocarditis and preparation method and use thereof |
Non-Patent Citations (1)
Title |
---|
孟庆轩等: "《循环系统常见病防治》", 30 September 2006 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105582308A (en) * | 2015-10-15 | 2016-05-18 | 张金祝 | Traditional Chinese medicine composition for treating myocarditis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103212040B (en) | Chinese medicinal composition for treatment of seborrheic alopecia | |
CN103536854B (en) | Traditional Chinese medicine composition capable of effectively treating neurasthenia, and preparation method thereof | |
CN104147447A (en) | Traditional Chinese medicine for treating pulmonary emphysema | |
CN103330821B (en) | A kind of Chinese medicine for the treatment of obstruction of qi in the chest and cardialgia | |
CN103720981A (en) | Traditional Chinese medicine for treating dysentery | |
CN104398923A (en) | Traditional Chinese medicine for treating eczema | |
CN103705855A (en) | Traditional Chinese medicine for treating thyroiditis | |
CN103845553A (en) | Traditional Chinese medicine for treating myocarditis | |
CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
CN102641484A (en) | Preparation method of traditional Chinese medicine for treating qi-deficiency-type ecthyma | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN104258299A (en) | Traditional Chinese medicine for treating mumps | |
CN104069453A (en) | Traditional Chinese medicine for treating chronic nephritis | |
CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
CN103479871A (en) | Medicine for treating myocarditis | |
CN103479952A (en) | Summer-heat relieving soup | |
CN102641485A (en) | Preparation method of traditional Chinese medicine for treating blood-deficiency-type ecthyma | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN102614478B (en) | Preparation method for traditional Chinese medicinal lotion for treating kidney Yin deficiency type ecthyma | |
CN104940790A (en) | Traditional Chinese medicine for treating psychoneurosis | |
CN104383211A (en) | Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy | |
CN103908573A (en) | Traditional Chinese medicine for treating constipation | |
CN103768489B (en) | A kind of diabetes injection care drug and preparation method thereof | |
CN1171611C (en) | Powder medicine for treating cerebritis | |
CN104510827A (en) | Traditional Chinese medicine for treating acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140611 |
|
WD01 | Invention patent application deemed withdrawn after publication |